• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至2021年斑秃及其相关合并症的全球、区域和国家负担以及到2050年的预测:全球疾病负担研究2021分析

Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990-2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021.

作者信息

Wang Dan, Deng Peizhi, Yang Shengbo, Xu Yangfan, Lu Jianyun

机构信息

Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, P. R. China.

Department of Dermatology, The Third Xiangya Hospital, Central South University, Changsha, Hunan Province, P. R. China; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

出版信息

Acta Derm Venereol. 2025 Aug 18;105:adv43367. doi: 10.2340/actadv.v105.43367.

DOI:10.2340/actadv.v105.43367
PMID:40824159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12376388/
Abstract

There are no updated epidemiological data on alopecia areata up to 2021. The objective of this study was to emphasize the urgency of addressing the evolving public health challenges of alopecia areata. The annual point prevalence, incidence, and years lived with disability of alopecia areata from 204 countries and regions from 1990-2021 were extracted. Subgroup analyses based on gender, age, global, national, regional, sociodemographic index, and World Bank income were conducted. From 1990-2021, age-standardized prevalence, incidence, and years lived with disability of alopecia areata globally show a decreasing trend, with females dominating. There was a reduction in the disease burden in high sociodemographic index regions, but alopecia areata in general did not reflect a concentration in certain regions and was more equally distributed. Decomposition analysis revealed that population growth was the major contributor to the burden of alopecia areata, followed by population ageing. Patients with alopecia areata before the age of 14 were associated with anxiety disorders and other psychological disorders, but patients after the age of 14 were not associated with the onset of these disorders. Also, atopic dermatitis has been associated with alopecia areata. The epidemiological differences in psychological disorders between children and adolescents/adults with alopecia areata further demonstrate the importance of differentiated recognition at different ages.

摘要

截至2021年,尚无斑秃的最新流行病学数据。本研究的目的是强调应对斑秃不断演变的公共卫生挑战的紧迫性。提取了1990年至2021年来自204个国家和地区的斑秃年点患病率、发病率和伤残调整生命年。基于性别、年龄、全球、国家、地区、社会人口指数和世界银行收入进行了亚组分析。从1990年到2021年,全球斑秃的年龄标准化患病率、发病率和伤残调整生命年呈下降趋势,女性占主导。社会人口指数高的地区疾病负担有所减轻,但总体而言,斑秃并不集中在某些地区,分布更为均匀。分解分析表明,人口增长是斑秃负担的主要贡献因素,其次是人口老龄化。14岁之前患斑秃的患者与焦虑症和其他心理障碍有关,但14岁之后的患者与这些障碍的发病无关。此外,特应性皮炎与斑秃有关。斑秃儿童与青少年/成人心理障碍的流行病学差异进一步证明了不同年龄分层识别的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/32a7ee68856a/ActaDV-105-43367-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/9610a86f6be8/ActaDV-105-43367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/3ff218b47b58/ActaDV-105-43367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/cb064ceb608b/ActaDV-105-43367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/971f85f578ff/ActaDV-105-43367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/25fdac8361af/ActaDV-105-43367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/a16d808b182a/ActaDV-105-43367-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/32a7ee68856a/ActaDV-105-43367-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/9610a86f6be8/ActaDV-105-43367-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/3ff218b47b58/ActaDV-105-43367-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/cb064ceb608b/ActaDV-105-43367-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/971f85f578ff/ActaDV-105-43367-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/25fdac8361af/ActaDV-105-43367-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/a16d808b182a/ActaDV-105-43367-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe38/12376388/32a7ee68856a/ActaDV-105-43367-g007.jpg

相似文献

1
Global, Regional, and National Burden of Alopecia Areata and its Associated Comorbidities, 1990-2021, and Projections to 2050: An Analysis of the Global Burden of Disease Study 2021.1990年至2021年斑秃及其相关合并症的全球、区域和国家负担以及到2050年的预测:全球疾病负担研究2021分析
Acta Derm Venereol. 2025 Aug 18;105:adv43367. doi: 10.2340/actadv.v105.43367.
2
Burden of knee osteoarthritis in China and globally: 1990-2045.中国及全球膝关节骨关节炎负担:1990 - 2045年
BMC Musculoskelet Disord. 2025 Jul 1;26(1):582. doi: 10.1186/s12891-025-08858-8.
3
The global burden of fractures and its underlying etiologies: results from and further analysis of the Global Burden of Disease Study 2021.骨折的全球负担及其潜在病因:2021年全球疾病负担研究的结果及进一步分析
Arch Osteoporos. 2025 Aug 6;20(1):111. doi: 10.1007/s11657-025-01596-3.
4
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.口服酪氨酸激酶3/肝细胞癌中表达的酪氨酸激酶家族激酶抑制剂芦可替尼24个月的疗效和安全性:斑秃的ALLEGRO IIb/III期和长期III期临床研究的综合分析
Br J Dermatol. 2025 Jan 24;192(2):215-227. doi: 10.1093/bjd/ljae365.
5
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment.在两项III期试验中,巴瑞替尼治疗重度斑秃成人患者长达4年(中位治疗时间2.3年)的安全性。
Am J Clin Dermatol. 2025 Apr 11. doi: 10.1007/s40257-025-00932-0.
6
The burden of cardiovascular disease in adolescents in China and globally due to sugar-sweetened beverage consumption from 1990 to 2021: results from the global burden of disease study 2021.1990年至2021年中国及全球青少年因饮用含糖饮料导致的心血管疾病负担:全球疾病负担研究2021的结果
BMC Public Health. 2025 Aug 15;25(1):2788. doi: 10.1186/s12889-025-24160-7.
7
Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021.全球、区域和国家阑尾炎负担的趋势和水平:2021 年全球疾病负担研究的发现。
Lancet Gastroenterol Hepatol. 2024 Sep;9(9):825-858. doi: 10.1016/S2468-1253(24)00157-2. Epub 2024 Jul 17.
8
Beyond hair loss: Exploring the psychiatric burden of alopecia areata in a large cohort.脱发之外:在一个大型队列中探索斑秃的精神负担
J Natl Med Assoc. 2025 Oct;117(5):335-340. doi: 10.1016/j.jnma.2025.07.008. Epub 2025 Jul 24.
9
Global, regional and national burdens of otitis media in children and adolescents from 1990 to 2021 and its predictions to 2040.1990年至2021年全球、区域和国家儿童及青少年中耳炎负担及其到2040年的预测。
Front Public Health. 2025 Jul 3;13:1552405. doi: 10.3389/fpubh.2025.1552405. eCollection 2025.
10
Global, Regional, and National Burden and Trends of Soft Tissue and Other Extraosseous Sarcomas From 1990 to 2021.1990年至2021年全球、区域和国家软组织及其他骨外肉瘤的负担与趋势
Cancer Control. 2025 Jan-Dec;32:10732748251355841. doi: 10.1177/10732748251355841. Epub 2025 Jun 28.

本文引用的文献

1
Trends in the global burden of disease for mental disorders among children aged 0-14 years, 1990-2021.1990年至2021年0至14岁儿童精神障碍的全球疾病负担趋势。
J Affect Disord. 2025 Sep 15;385:119325. doi: 10.1016/j.jad.2025.04.156. Epub 2025 Apr 26.
2
Global burden of malaria and neglected tropical diseases in children and adolescents, 1990-2019: a population-based, cross-sectional study.1990 - 2019年儿童和青少年疟疾及被忽视热带病的全球负担:一项基于人群的横断面研究
J R Soc Med. 2025 Mar;118(3):82-96. doi: 10.1177/01410768251321572. Epub 2025 Feb 26.
3
Findings from the Global Burden of Disease Study 2021.
《2021年全球疾病负担研究》的研究结果。
Lancet. 2024 May 18;403(10440):2259-2262. doi: 10.1016/S0140-6736(24)00769-4.
4
COVID-19 Associated With Higher Risk of Autoimmune Diseases.新冠病毒感染与自身免疫性疾病风险升高相关。
JAMA. 2024 Apr 16;331(15):1266. doi: 10.1001/jama.2024.2092.
5
Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: An analysis of the global burden of disease study 2019.全球、地区和国家炎症性肠病及其相关贫血的负担,1990 年至 2019 年,并预测至 2050 年:2019 年全球疾病负担研究分析。
Autoimmun Rev. 2024 Mar;23(3):103498. doi: 10.1016/j.autrev.2023.103498. Epub 2023 Dec 3.
6
Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.1990年至2020年全球、区域和国家类风湿性关节炎负担及到2050年的预测:全球疾病负担研究2021的系统分析
Lancet Rheumatol. 2023 Sep 25;5(10):e594-e610. doi: 10.1016/S2665-9913(23)00211-4. eCollection 2023 Oct.
7
Janus kinase inhibitors for alopecia areata.治疗斑秃的 Janus 激酶抑制剂。
J Am Acad Dermatol. 2023 Aug;89(2S):S29-S32. doi: 10.1016/j.jaad.2023.05.049.
8
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.美国雇主赞助的参保人群中成年人和儿童斑秃、全秃和普秃的患病率和发病率趋势。
JAMA Dermatol. 2023 Apr 1;159(4):411-418. doi: 10.1001/jamadermatol.2023.0002.
9
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.斑秃的负担:一项聚焦于生活质量、心理健康和工作效率的范围综述。
J Eur Acad Dermatol Venereol. 2023 Jan 27. doi: 10.1111/jdv.18926.
10
Global, regional and national burden of alopecia areata and its associated diseases, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.全球、地区和国家斑秃及其相关疾病负担,1990-2019 年:2019 年全球疾病负担研究的系统分析。
Eur J Clin Invest. 2023 Jun;53(6):e13958. doi: 10.1111/eci.13958. Epub 2023 Feb 7.